Integra LifeSciences
Holdings Corporation IART today announced that it has received
European CE Mark Certification for its Integra^® Flowable Wound Matrix, an
advanced device approved in the European Union for filling deep soft tissue or
tunneling wounds, including diabetic foot and leg ulcers.
The Société Française de Chirurgie Plastique Reconstructrice et Esthétique
(SOF.CPRE) (French Society of Reconstructive and Esthetic Plastic Surgery),
one of Europe's pre-eminent medical associations, has also awarded Integra's
Flowable Wound Matrix 1^st place in its innovation contest. Each year, over
1,000 surgeons attend the annual meeting and are asked to vote on the most
innovative new product, based on its performance. This year, the majority of
the voters selected Integra's Flowable Wound Matrix.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in